Imidazole analogues of fluoxetine, a novel class of anti-Candida agents

Journal of Medicinal Chemistry

Volumn 47, Issue 16, 2004, Pages 3924-3926

  Silvestri, Romano ^a   Artico, Marino ^a   La Regina, Giuseppe ^a   Di Pasquali, Alessandra ^a   De Martino, Gabriella ^a   D'Auria, Felicia Diodata ^a   Nencioni, Lucia ^a   Palamara, Anna Teresa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 CHLOROPHENYL) 1 (2,4 DICHLOROPHENOXY) 3 (1H IMIDAZOL 1 YL)PROPANE; ANTIFUNGAL AGENT; CHLORINE DERIVATIVE; CYTOTOXIC AGENT; ECONAZOLE; FLUCONAZOLE; FLUORINE DERIVATIVE; FLUOXETINE; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; METHYL GROUP; MICONAZOLE; NAFTIFINE; NITRO DERIVATIVE; PROPANE; SERTRALINE; TERBINAFINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CELL LINE, TUMOR; CELL SURVIVAL; FLUOXETINE; HUMANS; IMIDAZOLES; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 3242778536     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049856v     Document Type: Article

References (12)

1. Weinberg, E. D. Antifungal Agents. Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Wiley-Interscience: New York 1996; Vol. 2, pp 637-652.
2. Fungal Infections: Dermatomycoses. Drug R&D Backgrounder 2001, 1, 57-66.
3. Wildfeuer, A.; Seidl, H. P.; Paule, I.; Haberreiter, A. In vitro evaluation of voriconazole against clinical isolates of yeast, moulds, and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin and griseofulvin. Mycoses 1998, 41, 306-319.
4. Georgopapadakou, N. H. Antifungals: mechanism of action and resistance, established and novel drugs. Curr. Opin. Microbiol. 1998, 1, 547-557.
5. Sheehan, D. J.; Hitchcock, C. A.; Silbey, C. M. Current and emerging azole antifungal agents. Clin. Microbiol. Rev 1999, 12, 501-517.
6. (b) Watkins, W. J.; Renau, T. E. Progress with antifungal agents and approaches to combat fungal resistance. In Annual Reports in Medicinal Chemistry; Doherty, A. M., Ed., Academic Press: New York, 1999; Vol. 35, pp 157-166.
7. Ryder, N. S.; Squalene epoxidase as a target for the allylamines. Biochem. Soc. Trans. 1991, 19, 774-777.
8. Lass-Flörl, C.; Dierich, M. P.; Fuchs, D.; Semenitz, E.; Jenewein, I.; Ledochowski, M. Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J. Antimicrob. Chemother. 2001, 48, 775-779.
9. Massa, S.; Stefancich, G.; Corelli, F.; Silvestri, R.; Mai, A.; Artico, M.; Panico, S.; Simonetti, N. Research on antibacterical and antifungal agents. Synthesis and antifungal activities of 1-{p-methyl-alpha-[4-(1H-pyrrol-1-yl) phenyl]benzyl}azoles and some related products. Arch. Pharm. (Weinheim) 1989, 322, 369-373.
10. Stefancich, G.; Artico, M.; Ortar, G.; Silvestri, R.; Simonetti, G.; Apuzzo, G.; Artico, M. Synthesis and antifungal activity of structural analogues of bifonazole and ketoconazole. Arch. Pharm. (Weinheim) 1992, 325, 687-694.
11. Artico, M.; Ragno, R.; Porretta, G. C.; Massa, S.; Musiu, C.; Spiga, M. G.; Corrias, S.; La Colla, P. Iso-Miconazole and related derivatives: synthesis and antifungal activities. Med. Chem. Res. 1996, 137-147.
12. Villanova, P. A. Reference method for broth dilution antifungal susceptibility testing of yeast: aprroved standard. National Committee for Clinical Laboratory Standards 2002, Document M27-A2.